# Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors

> **NCT02342158** · NA · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 550 (actual)

## Conditions studied

- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** biopsy or surgical sampling
- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT02342158
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-12
- **Primary completion:** 2022-08-18
- **Final completion:** 2022-08-18
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342158, "Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02342158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*